Amneal Pharmaceuticals, Inc. AMRX 43.04
Health Care · NASDAQ · Data as of 2026-09-03
Amneal Pharmaceuticals, Inc. (AMRX) has delivered +12.6% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1254 of 1968 stocks overall and #150 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
43.04
Overall Rank
#1254 / 1968
Sector Rank
#150 / 260
Revenue CAGR
+12.6%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio